IBM's $12.5B AI Backlog Can't Halt Stock Slide as Inflation Fears Override Earnings Beat

IBM has built an artificial intelligence order book worth $12.5 billion and just posted a stronger-than-expected first quarter, yet its shares touched a fresh 52-week low this week. The gap between operational momentum and market reception underscores how macro pressures are overwhelming company-specific progress at the Dow component.

The culprit lies in hotter-than-anticipated US inflation data. Producer prices rose 6.0% year-on-year against a 4.9% consensus estimate, while core PPI clocked 5.2%. For investors who had been betting on an imminent pivot from the Federal Reserve, the numbers delivered an unwelcome jolt. Technology stocks with elevated valuations are especially sensitive to that repricing, and IBM was not spared despite its solid fundamentals.

Shares closed at €183.60 in German trading on Wednesday, down 1.87%, after earlier hitting €181.66 — a new 52-week trough. The year-to-date decline now exceeds 26%, and the stock has fallen well below its long-term moving average.

Institutional buyers see opportunity in the weakness

A striking counter-narrative is playing out among big institutional holders. The Virginia Retirement System boosted its IBM stake by a staggering 424.6% in the fourth quarter of 2025, taking ownership to more than 260,000 shares. Two smaller asset managers followed suit: Opinicus Capital increased its position by 78.1%, and Trek Financial by 47.0%. Such moves suggest that segments of the market view the selloff as disconnected from the company’s underlying trajectory.

Should investors sell immediately? Or is it worth buying IBM?

IBM's first-quarter 2026 numbers offer ammunition for that view. Revenue reached $15.92 billion, up 9.5% year-on-year, while earnings per share came in at $1.91 — comfortably above Wall Street’s forecasts. Free cash flow in the preceding quarter expanded by 23%, supporting a quarterly dividend that was recently raised to $1.69 per share. At the current price, that yields roughly 3.1%.

Red Hat remains the engine of enterprise AI

Strategically, IBM continues to bet heavily on Red Hat as the foundation for corporate artificial intelligence. At the Red Hat Summit in Atlanta, the company unveiled a partnership with Boomi aimed at building an integrated technology stack for agentic AI — autonomous software agents that can act on enterprise data.

Sovereign cloud infrastructure is another focal point. IBM is working with Core42 to deploy AI-ready platforms in the United Arab Emirates, using Red Hat OpenShift to meet local data residency and governance requirements. Industries with strict regulatory constraints are the primary target.

Product rollouts are accelerating. Red Hat AI Inference is scheduled to become available on IBM Cloud by the end of May 2026, followed by the OpenShift Virtualization Service in June. The second-quarter earnings report in July will be the first real test of how much of that pipeline is translating into top-line growth and margin expansion.

IBM at a turning point? This analysis reveals what investors need to know now.

Analyst optimism on software pivot

Market observers point to IBM’s deliberate shift toward higher-margin software and consulting as a structural advantage, especially when compared with hardware-heavy rivals such as Qualcomm. The company's deep integration into corporate IT infrastructure creates a sticky customer base that is unlikely to churn during the transition to new AI models.

Management has reaffirmed its full?year 2026 target of currency?adjusted revenue growth above 5%. With a $12.5 billion generative AI backlog already in the books and a string of product launches ahead, the operational narrative is far from broken. The question is whether the inflation-driven selloff will eventually give way to the underlying earnings story — or whether macro headwinds have more room to run.

Ad

IBM Stock: New Analysis - 14 May

Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IBM analysis...

en | US4592001014 | IBMS | boerse | 69328920 |